Autonomic and neuroendocrine actions of adrenomedullin in the brain: Mechanisms for homeostasis

Regulatory Peptides

Volumn 112, Issue 1-3, 2003, Pages 33-40

  Shan, Jing ^a   Stachniak, Tevye ^a   Jhamandas, Jack H ^a   Krukoff, Teresa L ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Area postrema; Fos immunohistochemistry; Nitric oxide; Paraventricular nucleus; RAMP2; Sympathetic output

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CORTICOTROPIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; NITRIC OXIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN; TYROSINE 3 MONOOXYGENASE;

AREA POSTREMA; AUTONOMIC NERVE; AUTONOMIC NERVOUS SYSTEM; BRAIN ELECTROPHYSIOLOGY; BRAIN NERVE CELL; CELL ACTIVATION; CHOLINERGIC NERVE CELL; CORTICOTROPIN BLOOD LEVEL; FOREBRAIN; HOMEOSTASIS; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; NERVE CELL EXCITABILITY; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 12244307889     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(03)00020-X     Document Type: Review

References (56)

1. Kitamura K., Sakata J., Kangawa K., Kojima M., Matsuo H., Eto T. Cloning and characterization of cDNA encoding a precursor for human adrenomedullin. Biochem. Biophys. Res. Commun. 194:1993;720-725.
2. Ichiki Y., Kitamura K., Kangawa K., Kawamoto M., Matsuo H., Eto T. Distribution and characterization of immunoreactive adrenomedullin in human tissue and plasma. FEBS Lett. 338:1994;6-10.
3. Martinez A., Miller M.J., Unsworth E.J., Siegfried J.M., Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumors. Endocrinology. 136:1995;4099-4105.
4. Miller M.J., Martinez A., Unsworth E.J., Thiele C.J., Moody T.W., Elsasser T.et al. Adrenomedullin expression in human tumor cell lines. Its potential role as an autocrine growth factor. J. Biol. Chem. 271:1996;23345-23351.
5. Nishimura J., Seguchi H., Sakihara C., Kureishi Y., Yoshimura H., Kobayashi S.et al. The relaxant effect of adrenomedullin on particular smooth muscles despite a general expression of its mRNA in smooth muscle, endothelial and epithelial cells. Br. J. Pharmacol. 120:1997;193-200.
6. Sakata J., Shimokubo T., Kitamura K., Nishizono M., Iehiki Y., Kangawa K.et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett. 352:1994;105-108.
7. Ueta Y., Kitamura K., Isse T., Shibuya I., Kabashima N., Yamamoto S.et al. Adrenomedullin-immunoreactive neurons in the paraventricular and supraoptic nuclei of the rat. Neurosci. Lett. 202:1995;37-40.
8. Washimine H., Asada Y., Kitamura K., Ichiki Y., Hara S., Yamamoto Y.et al. Immunohistochemical identification of adrenomedullin in human, rat, and porcine tissue. Histochem. Cell Biol. 103:1995;251-254.
9. Parkes D.G., May C.N. ACTH-suppressive and vasodilator actions of adrenomedullin in conscious sheep. J. Neuroendocrinol. 7:1995;923-929.
10. Ebara T., Miura K., Okumura M., Matsuura T., Kim S., Yukimura T.et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur. J. Pharmacol. 263:1994;69-73.
11. Yamaguchi T., Baba K., Doi Y., Yano K. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells. Life Sci. 56:1995;379-387.
12. Murphy T.C., Samson W.K. The novel vasoactive hormone, adrenomedullin, inhibits water drinking in the rat. Endocrinology. 136:1995;2459-2463.
13. Samson W.K. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu. Rev. Physiol. 61:1999;363-389.
14. Samson W.K., Murphy T.C. Adrenomedullin inhibits salt appetite. Endocrinology. 138:1997;613-616.
15. Israel A., Diaz E. Diuretic and natriuretic action of adrenomedullin administered intracerebroventricularly in conscious rats. Regul. Pept. 89:2000;13-18.
16. Shan J., Krukoff T.L. Distribution of preproadrenomedullin mRNA in the rat central nervous system and its modulation by physiological stressors. J. Comp. Neurol. 432:2001;88-100.
17. Shan J., Krukoff T.L. Intracerebroventricular adrenomedullin stimulates the hypothalamic-pituitary-adrenal axis, the sympathetic nervous system and production of hypothalamic nitric oxide. J. Neuroendocrinol. 13:2001;975-984.
18. Satoh F., Takahashi K., Murakami O., Totsune K., Sone M., Ohneda M.et al. Immunocytochemical localization of adrenomedullin-like immunoreactivity in the human hypothalamus and the adrenal gland. Neurosci. Lett. 203:1996;207-210.
19. Serrano J., Uttenthal L.O., Martinez A., Fernandez A.P., de Velasco J.M., Alonso D.et al. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res. 853:2000;245-268.
20. Takahashi K., Satoh F., Sone M., Murakami O., Sasano H., Mouri T.et al. Expression of adrenomedullin mRNA in the human brain and pituitary. Peptides. 18:1997;1051-1053.
21. Ueta Y., Hara Y., Setiadji V.S., Isse T., Shibuya I., Kitamura K.et al. Adrenomedullin-like immunoreactivity in the rat hypothalamo-neurohypophysial tract. Peptides. 20:1999;199-204.
22. Hwang I.S., Tang F. The distribution and gene expression of adrenomedullin in the rat brain: peptide/mRNA and precursor/active peptide relationships. Neurosci. Lett. 267:1999;85-88.
23. Juaneda C., Dumont Y., Chabot J.G., Quirion R. Autoradiographic distribution of adrenomedullin receptors in the rat brain. Eur. J. Pharmacol. 421:2001;R1-R2.
24. Sone M., Takahashi K., Satoh F., Murakami O., Totsune K., Ohneda M.et al. Specific adrenomedullin binding sites in the human brain. Peptides. 18:1997;1125-1129.
25. Buhlman N., Leuthauser K., Muff R., Fischer J.A., Born W. A receptor activity modifying protein (RAMP)2-dependent adrenomedullin receptor is a calcitonin gene-related peptide receptor when coexpressed with human RAMP. Endocrinology. 140:1999;2883-2980.
26. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N.et al. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
27. Chakravarty P., Suthar T.P., Coppock H.A., Nicholl C.G., Bloom S.R., Legon S.et al. CGRP and adrenomedullin binding correlates with transcript levels for calcitonin receptor-like receptor (CRLR) and receptor activity modifying proteins (RAMPs) in rat tissues. Br. J. Pharmacol. 130:2000;189-195.
28. Husmann K., Sexton P.M., Fischer J.A., Born W. Mouse receptor-activity-modifying proteins 1, -2, and -3: amino acid sequence, expression and function. Mol. Cell Endocrinol. 162:2000;35-43.
29. Oliver K.R., Kane S.A., Salvatore C.A., Mallee J.J., Kinsey A.M., Koblan K.S.et al. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat. Eur. J. Neurosci. 14:2001;618-628.
30. Ueda T., Ugawa S., Saishin Y., Shimada S. Expression of receptor-activity modifying protein (RAMP) mRNAs in the mouse brain. Mol. Brain Res. 93:2001;36-45.
31. Owji A.A., Smith D.M., Coppock H.A., Morgan D.G., Bhogal R., Ghatei M.A.et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology. 136:1995;2127-2134.
32. Allen M.A., Ferguson A.V. In vitro recordings from area postrema neurons demonstrate responsiveness to adrenomedullin. Am. J. Physiol. 270:1996;R920-R925.
33. Allen M.A., Smith P.M., Ferguson A.V. Adrenomedullin microinjection into the area postrema increases blood pressure. Am. J. Physiol. 272:1997;R1698-R1703.
34. Shan J., Krukoff T.L. Area postrema ablation attenuates activation of neurones in the paraventricular nucleus in response to systemic adrenomedullin. J. Neuroendocrinol. 12:2000;802-810.
35. Ueta Y., Hara Y., Kitamura K., Kangawa K., Eto T., Hattori Y.et al. Action sites of adrenomedullin in the rat brain: functional mapping by Fos expression. Peptides. 22:2001;1817-1824.
36. Saita M., Shimokawa A., Kunitake T., Kato K., Hanamori T., Kitamura K.et al. Central actions of adrenomedullin on cardiovascular parameters and sympathetic outflow in conscious rats. Am. J. Physiol. 274:1998;R979-R984.
37. Samson W.K., Murphy T.C., Resch Z.T. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats. Am. J. Physiol. 274:1998;R1505-R1509.
38. Takahashi H., Watanabe T.X., Nishimura M., Nakanishi T., Sakamoto M., Yoshimura M.et al. Centrally induced vasopressor and sympathetic responses to a novel endogenous peptide, adrenomedullin, in anesthetized rats. Am. J. Hypertens. 7:1994;478-482.
39. Matsumura K., Abe I., Tsuchihashi T., Fujishima M. Central adrenomedullin augments the baroreceptor reflex in conscious rabbits. Hypertension. 33:1999;992-997.
40. Smith P.M., Ferguson A.V. Adrenomedullin acts in the rat paraventricular nucleus to decrease blood pressure. J. Neuroendocrinol. 13:2001;467-471.
41. Aston-Jones G., Shipley M.T., Chouvet G., Ennis M., Van Bockstaele E., Pieribone V.et al. Afferent regulation of locus coeruleus neurones: anatomy, physiology and pharmacology. Prog. Brain Res. 88:1991;47-75.
42. Samson W.K., Murphy T., Schell D.A. A novel vasoactive peptide, adrenomedullin, inhibits pituitary adrenocorticotropin release. Endocrinology. 136:1995;2349-2352.
43. Charles C.J., Rademaker M.T., Richards A.M., Cooper G.J., Coy D.H., Nicholls M.G. Hemodynamic, hormonal, and renal effects of intracerebroventricular adrenomedullin in conscious sheep. Endocrinology. 139:1998;1746-1751.
44. Serino R., Ueta Y., Hara Y., Nomura M., Yamamoto Y., Shibuya I.et al. Centrally administered adrenomedullin increases plasma oxytocin level with induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of the rat. Endocrinology. 140:1999;2334-2342.
45. Ueta Y., Serino R., Shibuya I., Kitamura K., Kangawa K., Russell J.A.et al. A physiological role for adrenomedullin in rats; a potent hypotensive peptide in the hypothalamo-neurohypophysial system. Exp. Physiol. 85:2000;163S-169S. [Spec. No.].
46. Yokoi H., Arima H., Murase T., Kondo K., Iwasaki Y., Oiso Y. Intracerebroventricular injection of adrenomedullin inhibits vasopressin release in conscious rats. Neurosci. Lett. 216:1996;65-67.
47. Krukoff T.L. Central actions of nitric oxide in regulation of autonomic functions. Brain Res. Rev. 30:1999;52-65.
48. Bains J.S., Ferguson A.V. Nitric oxide regulates NMDA-driven GABAergic inputs to type I neurons of the rat paraventricular nucleus. J. Physiol. 499:1997;733-746.
49. Zhang K., Patel K.P. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am. J. Physiol. 275:1998;R728-R734.
50. + channels. Am. J. Physiol. 279:2000;H2620-H2626.
51. Yang B.C., Lippton H., Gumusel B., Human A., Mehta J.L. Adrenomedullin dilates rat pulmonary artery rings during hyposia: role of nitric oxide and vasodilator prostaglandins. J. Cardiovasc. Pharmacol. 28:1996;458-462.
52. Jhamandas J.H., Renaud L.P. A GABA-mediated baroreceptor input to supraoptic vasopressin neurones in the rat. J. Physiol. 381:1986;595-606.
53. Jhamandas J.H., Renaud L.P. Diagonal band neurons may mediate arterial baroreceptor input to hypothalamic vasopressin-secreting neurons. Neurosci. Lett. 65:1986;214-218.
54. Givens B.S., Olton D.S. Cholinergic and GABAergic modulation of medial septal area: effect on working memory. Behav. Neurosci. 104:1990;849-855.
55. Jhamandas J.H., Raby W., Rogers J., Buijs R.M., Renaud L.P. Diagonal band projection towards the hypothalamic supraoptic nucleus: light and electron microscopic observations in the rat. J. Comp. Neurol. 282:1989;15-23.
56. Jhamandas J.H., Cho C., Jassar B.S., Harris K.H., MacTavish D., Easaw J. Cellular mechanisms for amyloid β-protein activation of rat cholinergic basal forebrain neurons. J. Neurophysiol. 86:2001;1312-1320.